The impact of mpMRI-targeted vs systematic biopsy on the risk of prostate cancer downgrading at final pathology

Stabile, A.
DOI: https://doi.org/10.1007/s00345-024-04963-w
2024-04-23
World Journal of Urology
Abstract:Although targeted biopsies (TBx) are associated with improved disease assessment, concerns have been raised regarding the risk of prostate cancer (PCa) overgrading due to more accurate biopsy core deployment in the index lesion.
urology & nephrology
What problem does this paper attempt to address?